OYST Projected Dividend Yield
Oyster Point Pharma Inc ( NASDAQ : OYST )Oyster Point Pharma is a biopharmaceutical company focused on the discovery, development and commercialization of pharmaceutical therapies to treat ophthalmic diseases. Co.'s development pipeline includes: Small Molecule Programs, which consist of Tyrvaya™ (varenicline solution) Nasal Spray for the indication of dry eye disease, and OC-01 (varenicline solution) nasal spray for the indication of Neurotrophic Keratopathy Stage 1; and ETF™ Gene Therapy Approach, which consists of OC-101 adeno-associated virus (AAV)-Nerve Growth Factor for the indication of Neurotrophic Keratopathy Stage 2 and 3, and OC-103 AAV for the indication of Vernal Keratoconjunctivitis/Severe Allergic Conjunctivitis. 20 YEAR PERFORMANCE RESULTS |
OYST Dividend History Detail OYST Dividend News OYST Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |